{
    "topic": "healthcare",
    "source": "USA TODAY",
    "bias": 1,
    "url": "https://www.usatoday.com/story/money/2019/11/14/dollar-tree-otc-drugs-fda-warning-letter-assured-brand/4199656002/",
    "title": "FDA sends Dollar Tree warning letter for selling 'potentially unsafe drugs' from Chinese suppliers",
    "date": "2019-11-14",
    "authors": "",
    "content": "Dollar Tree is under fire for stocking \u201c potentially unsafe drugs \u201d and cosmetics .\nThe Food and Drug Administration said in a news release on Thursday it sent a warning letter to Greenbrier International Inc. , which does business as Dollar Tree , outlining \u201c multiple violations of current good manufacturing practices at contract manufacturers used to produce Dollar Tree \u2019 s Assured Brand OTC drugs \u201d and other products sold at Dollar Tree and Family Dollar stores .\n\u201c Americans expect and deserve drugs that are safe , effective and that meet our standards for quality , \u201d Donald D. Ashley , director of the Office of Compliance in the FDA \u2019 s Center for Drug Evaluation and Research , said in the release . \u201c In this case , Dollar Tree has the ultimate responsibility to ensure that it does not sell potentially unsafe drugs and other FDA-regulated products to Americans . \u201d\nIn the Nov. 6 letter to Dollar Tree CEO Gary Philbin , the FDA identifies Chinese manufacturers that failed to test products and cited an example where \u201c rodent feces ( were ) found throughout the manufacturing facility . \u201d\nChicken recall : More than 2 million pounds recalled , may be contaminated with metal\nAccording to the FDA , Dollar Tree received warning letters between 2016 and 2019 , including notification of letters sent to the manufacturers who were placed on \u201c import alert , which are used to prevent potentially violative products from being imported into the U.S. market . \u201d\nRandy Guiler , Dollar Tree \u2019 s vice president of investor relations , said in a statement to CNBC that the items referenced by the FDA were \u201c topical , not ingestible products . \u201d\n\u201c We are committed to our customers \u2019 safety and have very robust and rigorous testing programs in place to ensure our third-party manufacturers \u2019 products are safe , \u201d Guiler said in the statement to CNBC , noting the company was cooperating and plans to meet with FDA in the near future .\nBlack Friday 2019 : Get a jump on holiday shopping plans with early look at ads\nThe FDA is asking Dollar Tree to \u201c provide a detailed plan to ensure you do not receive or deliver adulterated drugs in interstate commerce \u201d and a plan to audit suppliers .\nDollar Tree also was asked to schedule a meeting within 15 working days of receiving the letter and to \u201c determine if you have any remaining drugs in your possession , either in your distribution network or in retail stores under the Dollar Tree , Family Dollar or any other retail store brands in your network . \u201d",
    "content_original": "USA TODAY\n\nDollar Tree is under fire for stocking \u201cpotentially unsafe drugs\u201d and cosmetics.\n\nThe Food and Drug Administration said in a news release on Thursday it sent a warning letter to Greenbrier International Inc., which does business as Dollar Tree, outlining \u201cmultiple violations of current good manufacturing practices at contract manufacturers used to produce Dollar Tree\u2019s Assured Brand OTC drugs\u201d and other products sold at Dollar Tree and Family Dollar stores.\n\n\u201cAmericans expect and deserve drugs that are safe, effective and that meet our standards for quality,\u201d Donald D. Ashley, director of the Office of Compliance in the FDA\u2019s Center for Drug Evaluation and Research, said in the release. \u201cIn this case, Dollar Tree has the ultimate responsibility to ensure that it does not sell potentially unsafe drugs and other FDA-regulated products to Americans.\u201d\n\nIn the Nov. 6 letter to Dollar Tree CEO Gary Philbin, the FDA identifies Chinese manufacturers that failed to test products and cited an example where \u201crodent feces (were) found throughout the manufacturing facility.\u201d\n\nChicken recall:More than 2 million pounds recalled, may be contaminated with metal\n\nAccording to the FDA, Dollar Tree received warning letters between 2016 and 2019, including notification of letters sent to the manufacturers who were placed on \u201cimport alert, which are used to prevent potentially violative products from being imported into the U.S. market.\u201d\n\nRandy Guiler, Dollar Tree\u2019s vice president of investor relations, said in a statement to CNBC that the items referenced by the FDA were \u201ctopical, not ingestible products.\u201d\n\n\u201cWe are committed to our customers\u2019 safety and have very robust and rigorous testing programs in place to ensure our third-party manufacturers\u2019 products are safe,\u201d Guiler said in the statement to CNBC, noting the company was cooperating and plans to meet with FDA in the near future.\n\nBlack Friday 2019:Get a jump on holiday shopping plans with early look at ads\n\nThe FDA is asking Dollar Tree to \u201cprovide a detailed plan to ensure you do not receive or deliver adulterated drugs in interstate commerce\u201d and a plan to audit suppliers.\n\nDollar Tree also was asked to schedule a meeting within 15 working days of receiving the letter and to \u201cdetermine if you have any remaining drugs in your possession, either in your distribution network or in retail stores under the Dollar Tree, Family Dollar or any other retail store brands in your network.\u201d\n\nFollow USA TODAY reporter Kelly Tyko on Twitter: @KellyTyko",
    "source_url": "www.usatoday.com",
    "bias_text": "center",
    "ID": "QKC3MDY7CYRVvja8"
}